| Abstract | Many therapeutic agents have been tried with variable success in the treatment of Felty neutropenia, but the reports are anecdotal. We now describe the second trial of recombinant granulocyte-macrophage colony-stimulating factor (GM-CSF), in a splenectomized, infected patient with Felty syndrome. |
| Authors | G Joseph, D H Neustadt, J Hamm, M Kellihan, T Hadley
(Affiliation: Divsion of Hematology/Oncology, James Graham Brown Cancer Center.)
|
| Journal | American journal of hematology
(Am J Hematol)
Vol. 37
Issue 1
Pg. 55-6
(May 1991)
ISSN: 0361-8609 UNITED STATES |
| PMID | 2024642
(Publication Type: Case Reports, Journal Article)
|
| Chemical References |
- Recombinant Proteins
- Granulocyte-Macrophage Colony-Stimulating Factor
|
| Topics |
- Felty's Syndrome
(drug therapy)
- Granulocyte-Macrophage Colony-Stimulating Factor
(therapeutic use)
- Humans
- Male
- Middle Aged
- Neutropenia
(drug therapy)
- Recombinant Proteins
(therapeutic use)
|
